Live Breaking News & Updates on Immunic Inc Nasdaq

Stay updated with breaking news from Immunic inc nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-News: Immunic AG: Immunic to Participate in Industry and Scientific Conferences in June

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible ....

Den Haag , Zuid Holland , United States , San Diego , Jessica Breu , Edna Kaplan , Werner Gladdines , Paula Schwartz , Contract Management Group , Rx Communications Group , Distribution Services , Immunic Inc , International Convention , Exchange Commission , Immunic Inc Nasdaq , Communications Of Immunic , Program Management Clinical Development Operations Of Immunic , Scientific Conferences , Vice President Investor Relations , Pharmaceutical Contract Management Group , Vice President , Program Management , Clinical Development Operations , Private Securities Litigation Reform Act , Middle East , Annual Report ,

EQS-News: Immunic AG: Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update

EQS-News: Immunic AG: Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Daniel Vitt , Edna Kaplan , Jessica Breu , Paula Schwartz , Trademark Office , Exchange Commission , Immunic Inc Nasdaq , Clinical Development Programs , Americas Committee For Treatment , Development Rd Expenses , Immunic Inc , Rx Communications Group , Distribution Services , Research In Multiple Sclerosis , Interim Statement , Reports First Quarter , Provides Corporate Update , Provides Corporate , Bolstered Balance Sheet Through , Extending Cash Runway Into , Third Quarter , Vidofludimus Calcium , Multiple Sclerosis , Relapsing Multiple Sclerosis , Progressive Multiple Sclerosis Remain Underway ,

EQS-News: Immunic, Inc.: Immunic Highlights 2023 Accomplishments and Upcoming Milestones

EQS-News: Immunic, Inc.: Immunic Highlights 2023 Accomplishments and Upcoming Milestones
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Paula Schwartz , Daniel Vitt , Jessica Breu , Richard Rudick , Edna Kaplan , Hella Kohlhof , Exchange Commission , Jp Morgan Health Care Conference , Corporate Community , Immunic Inc Nasdaq , Program In Relapsing Multiple Sclerosis Ongoing , International Business Gold Award , Distribution Services , Immunic Inc , Improvements In Gut Health Demonstrated Phase , Rx Communications Group , Upcoming Milestones , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population , All Subtypes , Relapsing Multiple Sclerosis Ongoing , Gut Health Demonstrated ,

Immunic (IMUX) Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium

Immunic (IMUX) Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Jens Kuhle , Daniel Vitt , Andreas Muehler , Immunic Inc Nasdaq , University Hospital , Sclerosis Centre , Senior Physician , Neuroimmunology Unit , Multiple Sclerosis Centre , Chief Executive Officer , Chief Medical Officer ,

Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for. ....

United States , Paula Schwartz , Andreas Muehler , Jessica Breu , Daniel Vitt , Edna Kaplan , Exchange Commission , Rx Communications Group , Immunic Inc Nasdaq , Immunic Inc , Unblinded Interim Biomarker Analysis Expected , Full Data Readout Expected , Chief Executive Officer , Chief Medical Officer , North America , Eastern Europe , Vidofludimus Calcium , Private Securities Litigation Reform Act , Annual Report , Investor Relations ,